At #Clinilabs, we are passionately committed to uncovering groundbreaking treatments for individuals facing complex neurological conditions. This dedication inspires us each day to challenge the limits and strive for a brighter tomorrow for those in need. Join us in celebrating #BrainAwarenessWeek and discover how the Clinilabs Advantage can elevate your projects to extraordinary heights. Together, we can make a meaningful impact! clinilabs.com #theCROforCNS
关于我们
Clinilabs is a global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development. With deep expertise in CNS, we are committed to the development of medicines that treat a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS diseases. Clinilabs partners with pharmaceutical and biotechnology companies to deliver a complete, first-in-human to Phase 3 spectrum of high-quality, timely, and cost-effective clinical therapeutic development services, with the shared goal of speeding new CNS medicines to market. We are process-driven yet structured to be nimble, providing personalized service that meets the needs of customers and projects of all sizes. Clinilabs has conducted more than 750 CNS clinical trials since 2000 and has played a pivotal role in approving 22 new therapies across 13 CNS indications to help transform patients’ lives worldwide.
- 网站
-
https://www.clinilabs.com
Clinilabs的外部链接
- 所属行业
- 研究服务
- 规模
- 201-500 人
- 总部
- Eatontown,NJ
- 类型
- 私人持股
- 创立
- 2000
- 领域
- Early-phase research、Data Management、CNS、CRO、Contract Research、Asian Bridging、Core Laboratories、Alzheimer's Disease、Substance Use Disorders、Mental Health Disorders、Neurotech、Phase I、Clinical Trial Management、Neurology和Psychiatry
地点
Clinilabs员工
-
Sylvia Pisconti
Experienced HR Professional
-
Jeanine Falinski
Senior Vice President, Commercial Development @ Clinilabs | The CRO for CNS
-
Luke Mark
Residency Program Coordinator
-
Angela Terhune Hargrove
Vice President at CRO - CNS, Psychedelics, Pharma, Biotech, CRO, AI, Addiction, Ketamine, Rare disease, Oncology, Medical Device, CGT
动态
-
One-third of the world suffers from sleep disorders, making a good night's sleep a cherished experience for many. At #Clinilabs, we harness decades of expertise to support both in-house and multicenter sleep studies with unparalleled insight and precision. Our Corelab data center stands out as a trailblazer in monitoring and collecting data while adeptly addressing a wide range of sleep disorders such as sleep apnea, insomnia, narcolepsy, idiopathic hypersomnia, restless leg syndrome, and more. By partnering with us, you gain access to cutting-edge technology and a wealth of knowledge, ensuring that your research yields the highest quality data and outcomes. Find out how we can be your expert in sleep and let’s redefine sleep health together! Visit https://loom.ly/L5oZPt4 today. #theCROforCNS #SleepResearch #WorldSleepDay
-
Clinilabs is pleased to announce its partnership with InTandem Capital Partners, a leading healthcare-focused private equity firm, to support our growth as we drive to become the preeminent provider of CNS drug and device development services industry-wide. To read the full press release visit: https://lnkd.in/e4NubQwZ
-
#Clinilabs proudly recognizes Nina Shu with the Above & Beyond award for her exceptional contributions to a recent project. She consistently managed demands while maintaining budgets and attention to detail. Join us in celebrating her outstanding work!
-
-
This month, the Journal of Clinical Sleep Research published an article titled "Performance of Consumer Wrist-Worn Sleep Tracking Devices Compared to Polysomnography: A Meta-Analysis." The article highlights the growing interest in sleep-tracking devices as more people recognize the importance of sleep and seek to monitor their sleep patterns. The analysis compares sleep-scoring data from various consumer wrist-worn sleep-tracking devices with the gold standard of polysomnography, aiming to validate the accuracy of these devices. At #Clinilabs, we have observed a significant increase in clinical research utilizing wrist-worn devices and possess the expertise to collect reliable data from these devices as well as traditional methods. If you are seeking a leader in sleep research to elevate your project, partner with us for your next sleep study and experience why our Corelab data center is recognized as a leader in sleep research. We excel in monitoring, collecting data, and effectively addressing a wide range of sleep disorders. To read the full article visit https://loom.ly/ko8OInw Contact Us: https://loom.ly/L5oZPt4 #theCROforCNS #SleepAwarenessWeek #SleepMatters
-
Today, #Clinilabs honors Gertrude Elion on #InternationalWomen’sDay. Gertrude, George H. Hitchings, and Sir James Black won the 1988 Nobel Prize in Physiology or Medicine for their groundbreaking work in rational drug design. This approach, which focuses on understanding the biochemical processes of diseases to create targeted treatments, led to the development of drugs for leukemia, gout, and malaria. Elion's contributions have significantly advanced medicine and improved the lives of many people suffering from various diseases. Like Mrs. Elion, Clinilabs' mission is to assist those in need by tirelessly collaborating with our sponsors to bring new CNS therapies to market. Whether it's neurological disorders, substance use disorders, mental health, or rare diseases our goal is to deliver innovative treatments that enhance lives. To find out more about Clinilabs visit www.clinilabs.com. To read more about Gertrude Elion and her remarkable story, visit https://loom.ly/cXlJm9M. #theCROforCNS #IWD #ClinicalResearch
-
-
Today and every day, we celebrate your unwavering dedication and determination to bring new CNS therapies to those in need. Thank you for making a profound impact on the world! #Clinilabs #Team #EmployeeAppreciation
-
As the Senior Manager of Quality and Regulatory Compliance, Kevin oversees #Clinilabs' quality management system, ensuring adherence to all relevant regulatory standards. Through internal audits, risk assessments, and corrective and preventive action plans, he ensures we maintain compliance. Kevin also leads a team of quality professionals, striving for excellence across all operations and products. We are grateful for his dedication and continuous excellence. Congratulations, Kevin, on being March's #EmployeeSpotlight!
-
-
Did you know individuals with TBI are nearly twice as likely to develop depressive symptoms compared to those without TBI. "Depression after traumatic brain injury: A systematic review and Meta-analysis" published in the American Journal of Emergency Medicine, included 43 studies. Among these, 15 reported new cases of depression post-TBI, while 34 compared depressive symptoms between TBI and non-TBI participants. The Meta-analysis found a 13% incidence among 724,842 TBI participants and a relative risk of 2.10 when comparing 106,083 TBI patients to 323,666 non-TBI controls. Eleven of the 43 studies were deemed to have a high risk of bias. Sensitivity analysis confirmed the robustness of the findings, and no publication bias was detected using Egger's regression test. To read the full article visit https://loom.ly/6DByZes To find out how you can partner with #Clinilabs on your next mental health study visit https://loom.ly/OzFAni0 #theCROforCNS
-
#Clinilabs is excited to announce our participation in #ASENT2025, the leading neurotherapeutics conference. Discover why industry leaders rely on Clinilabs for their CNS clinical research needs. Don’t miss this opportunity to collaborate with experts committed to excellence and innovation in neurotherapeutics. Schedule your meeting with us today and take the first step towards success! Schedule Now: https://loom.ly/D_B8rQU #theCROforCNS